Stay updated on Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Sign up to get notified when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:30:07.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website changes and links to transition updates and FAQs, noting that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T14:49:23.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:39:22.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:44:26.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The 403 error block was removed, allowing the page to display the study details rather than an error page.
    Difference
    0.5%
    Check dated 2026-09-28T17:32:09.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record. Visitors see the site’s error view instead of the NCT02788474 details.
    Difference
    17%
    Check dated 2026-09-21T21:49:12.000Z thumbnail image

Stay in the know with updates to Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.